Monopar Therapeutics
MNPR
#7831
Rank
HK$1.91 B
Marketcap
HK$313.80
Share price
-0.88%
Change (1 day)
1,133.30%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of December 2024 : HK$0.46 Billion

According to Monopar Therapeutics's latest financial reports the company has HK$0.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$56.74 M-44.64%
2022-12-31HK$0.10 B-35.25%
2021-12-31HK$0.15 B22.02%
2020-12-31HK$0.12 B26.08%
2019-12-31HK$0.10 B90.66%
2018-12-31HK$53.97 M-23.08%
2017-12-31HK$70.17 M336.62%
2016-12-31HK$16.07 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$1.98 B 325.10%๐Ÿ‡บ๐Ÿ‡ธ USA